Emerging Therapies in Food Allergy: A Clinical Update

Registration


CLICK “CONTINUE” AT THE BOTTOM OF THE PAGE TO COMPLETE YOUR REGISTRATION TO JOIN US IN WASHINGTON, DC.

CAN’T MAKE IT TO DC? CLICK “CONTINUE” AT THE BOTTOM OF THE PAGE AND SELECT THE LIVE STREAMING OPTION TO PARTICIPATE VIRTUALLY.

Monday, October 23, 2023
Buffet Dinner: 6:30 PM – 7:00 PM ET
Symposium: 7:00 PM – 8:30 PM ET

LIVE / LIVE VIRTUAL SYMPOSIUM

Westin Washington DC Downtown (formerly Renaissance Washington DC Downtown Hotel)
Meeting Room: Potomac Salon I, Ballroom Level (2 floors below the lobby)
999 9th St NW
Washington, DC 20001

Faculty 

Matthew Greenhawt, MD, MBA, MSc
Professor of Pediatrics
Children's Hospital Colorado
Department of Pediatrics
University of Colorado School of Medicine
Aurora, CO

Brian P. Vickery, MD
Professor of Pediatrics
Marcus Professor of Pediatric Immunology
Chief, Division of Allergy/Immunology 
Emory University & Children’s Healthcare of Atlanta
Atlanta, GA

Target Audience 

This activity has been designed to address the educational needs of pediatricians and allergists. It may also benefit other clinicians interested in the management of food allergy (FA). 

This symposium is not sponsored, endorsed, or accredited by the American Academy of Pediatrics.

Educational Provider

This activity is provided by Paradigm Medical Communications, LLC.  

Supporter Acknowledgment 

This activity is supported by an educational grant from Genentech, a member of the Roche Group.    

Program Overview

New insights on the immunopathology of food allergy have led to development of cautious use of controlled exposure to food allergens through allergen immunotherapy and emerging use of monoclonal antibody therapy to interfere with the synthesis of immunoglobulin (IgE). Expert faculty will contextualize the mechanisms and available clinical trial data related to the use of biologic agents in food allergy as monotherapy and as adjunct therapy to allergen immunotherapy.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe the immunopathology of FA and related mechanisms by which biologic agents may mediate FA
  • Summarize clinical trial safety and efficacy data related to the use of anti-IgE therapy in FA

Topics

6:30 PM – 7:00 PM ET    Registration and Complimentary Buffet Dinner
7:00 PM – 8:30 PM ET    Clinical Program
  • Food allergy in 2023
  • Immune pathology of IgE-mediated food allergy
  • Current management and treatment approaches to food allergy
  • Therapies targeting immunologic mechanisms underlying IgE-mediated food allergy
  • Faculty discussion 
  • Q&A session

Physician Accreditation Statement

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 

Physician Credit Designation Statement

Paradigm Medical Communications, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

PA Continuing Education 

PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner Continuing Education 

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Disclosure of Relevant Financial Relationships 

In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, Paradigm requires that all planners, faculty, and others who are in a position to control the content of this activity disclose all financial relationships with ineligible companies during the past 24 months.  Disclosure information about relevant financial relationships with ineligible companies (if any) for anyone contributing to content development will be included in materials distributed at the time of the activity. 

CME Inquiries

For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com.

Fee Information

There is no fee required for participation in this activity.

Click the "Register Now" button. Once registered, you will receive an email confirmation with the event details.

© 2023 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.